Abstract
Abstract:Anticonvulsant hypersensitivity syndrome (AHS) is a potentially life-threatening adverse drug reaction presenting with fever, skin eruptions, and internal organ involvement. We describe a case of AHS with fulminant hepatitis that occurred two weeks after introduction of lamotrigine in a 40-year-old female patient with a recently diagnosed bipolar disorder, no pre-existent systemic organ involvement, and no other medication. Lamotrigine was introduced at a dosage of 25 mg daily and increased to 50 mg daily 12 days later. The patient had favorable evolution with cessation of lamotrigine and supportive treatment. This report suggests that AHS with fulminant hepatitis may occur idiosyncratically, independent of dosage, titration and comedication with other potentially hepatotoxic drugs.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Malik S, Arif H, Hirsch LJ. Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders. Expert Rev Neurother 2006;6:1609–1627.MalikS]]ArifH]]HirschLJLamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Expert Rev Neurother200661609-16272. Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007;27:1425–1439.BohanKH]]MansuriTF]]WilsonNMAnticonvulsant hypersensitivity syndrome: implications for pharmaceutical care.Pharmacotherapy2007271425-14393. Schaub N, Bircher AJ. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 2000;55:191–193.SchaubN]]BircherAJSevere hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.Allergy200055191-1934. Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 1998;51:1172–1175.SchliengerRG]]KnowlesSR]]ShearNHLamotrigine-associated anticonvulsant hypersensitivity syndrome.Neurology1998511172-11755. Makin AJ, Fitt S, Williams R, et al. Fulminant hepatic failure induced by lamotrigine. BMJ 1995;311:292.MakinAJ]]FittS]]WilliamsR&etal;Fulminant hepatic failure induced by lamotrigine.BMJ19953112926. Arnon R, DeVivo D, Defelice AR, et al. Acute hepatic failure in a child treated with lamotrigine. Pediatr Neurol 1998;18:251–252.ArnonR]]DeVivoD]]DefeliceAR&etal;Acute hepatic failure in a child treated with lamotrigine.Pediatr Neurol199818251-2527. Veyrac G, Marcade G, Chiffoleau A, et al. Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes. Thérapie 2002;57:289–296.VeyracG]]MarcadeG]]ChiffoleauA&etal;Characteristics of hypersensitivity syndrome to lamotrigine: review of one case reported in the Regional Center of Pharmacovigilance of Nantes.Thérapie200257289-2968. Overstreet K, Costanza C, Behling C, et al. Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review. Dig Dis Sci 2002;47:1921–1925.OverstreetK]]CostanzaC]]BehlingC&etal;Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review.Dig Dis Sci2002471921-19259. Mecarelli O, Pulitano P, Mingoia M, et al. Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (MARS). Epilepsia 2005;46:1687–1689.MecarelliO]]PulitanoP]]MingoiaM&etal;Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (MARS).Epilepsia2005461687-1689
